Logo image of DPT.PA

S.T. DUPONT (DPT.PA) Stock Fundamental Analysis

EPA:DPT - Euronext Paris - Matif - FR0000054199 - Common Stock - Currency: EUR

0.101  +0 (+1%)

Fundamental Rating

2

Overall DPT gets a fundamental rating of 2 out of 10. We evaluated DPT against 42 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of DPT is average, but there are quite some concerns on its profitability. DPT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DPT had negative earnings in the past year.
DPT had a negative operating cash flow in the past year.
DPT had negative earnings in each of the past 5 years.
In multiple years DPT reported negative operating cash flow during the last 5 years.
DPT.PA Yearly Net Income VS EBIT VS OCF VS FCFDPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

DPT's Return On Assets of -1.88% is on the low side compared to the rest of the industry. DPT is outperformed by 76.19% of its industry peers.
The Return On Equity of DPT (-4.08%) is worse than 73.81% of its industry peers.
The Return On Invested Capital of DPT (0.50%) is worse than 76.19% of its industry peers.
Industry RankSector Rank
ROA -1.88%
ROE -4.08%
ROIC 0.5%
ROA(3y)-7.16%
ROA(5y)-13.62%
ROE(3y)-107.46%
ROE(5y)-111.33%
ROIC(3y)N/A
ROIC(5y)N/A
DPT.PA Yearly ROA, ROE, ROICDPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

With a Operating Margin value of 0.47%, DPT is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
DPT's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 55.91%, DPT perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Gross Margin of DPT has remained more or less at the same level.
Industry RankSector Rank
OM 0.47%
PM (TTM) N/A
GM 55.91%
OM growth 3YN/A
OM growth 5Y-37.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.1%
GM growth 5Y-0.81%
DPT.PA Yearly Profit, Operating, Gross MarginsDPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

5

2. Health

2.1 Basic Checks

DPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DPT has been increased compared to 1 year ago.
DPT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DPT has an improved debt to assets ratio.
DPT.PA Yearly Shares OutstandingDPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DPT.PA Yearly Total Debt VS Total AssetsDPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.07 indicates that DPT is not in any danger for bankruptcy at the moment.
DPT has a Altman-Z score of 3.07. This is in the better half of the industry: DPT outperforms 64.29% of its industry peers.
A Debt/Equity ratio of 0.30 indicates that DPT is not too dependend on debt financing.
DPT has a better Debt to Equity ratio (0.30) than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 3.07
ROIC/WACC0.06
WACC7.75%
DPT.PA Yearly LT Debt VS Equity VS FCFDPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

DPT has a Current Ratio of 1.76. This is a normal value and indicates that DPT is financially healthy and should not expect problems in meeting its short term obligations.
DPT's Current ratio of 1.76 is fine compared to the rest of the industry. DPT outperforms 69.05% of its industry peers.
A Quick Ratio of 1.02 indicates that DPT should not have too much problems paying its short term obligations.
DPT's Quick ratio of 1.02 is fine compared to the rest of the industry. DPT outperforms 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.02
DPT.PA Yearly Current Assets VS Current LiabilitesDPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DPT have decreased strongly by -150.00% in the last year.
Looking at the last year, DPT shows a small growth in Revenue. The Revenue has grown by 6.82% in the last year.
The Revenue has been decreasing by -0.22% on average over the past years.
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y19.2%
Revenue growth 5Y-0.22%
Sales Q2Q%1.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DPT.PA Yearly Revenue VS EstimatesDPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
DPT.PA Yearly EPS VS EstimatesDPT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
DPT.PA Price Earnings VS Forward Price EarningsDPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

DPT's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. DPT is more expensive than 80.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.26
DPT.PA Per share dataDPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

S.T. DUPONT

EPA:DPT (3/25/2025, 7:00:00 PM)

0.101

+0 (+1%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners90.6%
Ins Owner ChangeN/A
Market Cap95.31M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.78
P/FCF N/A
P/OCF N/A
P/B 3.64
P/tB 3.81
EV/EBITDA 33.26
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.06
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.88%
ROE -4.08%
ROCE 0.68%
ROIC 0.5%
ROICexc 0.59%
ROICexgc 0.61%
OM 0.47%
PM (TTM) N/A
GM 55.91%
FCFM N/A
ROA(3y)-7.16%
ROA(5y)-13.62%
ROE(3y)-107.46%
ROE(5y)-111.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-33.76%
ROICexc growth 3YN/A
ROICexc growth 5Y-31.48%
OM growth 3YN/A
OM growth 5Y-37.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.1%
GM growth 5Y-0.81%
F-Score4
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 2.57
Cap/Depr 89.25%
Cap/Sales 4.7%
Interest Coverage 0.16
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.02
Altman-Z 3.07
F-Score4
WACC7.75%
ROIC/WACC0.06
Cap/Depr(3y)125.52%
Cap/Depr(5y)84.1%
Cap/Sales(3y)6.59%
Cap/Sales(5y)5.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.82%
Revenue growth 3Y19.2%
Revenue growth 5Y-0.22%
Sales Q2Q%1.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y188.38%
EBIT growth 3YN/A
EBIT growth 5Y-37.61%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-264.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-144.55%
OCF growth 3YN/A
OCF growth 5YN/A